MOLN Competitors & Alternatives
Compare Molecular Partners AG ADR with similar stocks in the same industry
Biotechnology
MOLN
Main Stock$3.81
Tradestie Score
55
Market Cap
$138.88M
Revenue Growth
-1.0%
Analyst Upside
+183.8%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$9.13
|
$211.22M | - | 56 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.01
|
$202.58M | - | 56 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$18.23
|
$170.45M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$5.02
|
$158.43M | - | 51 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.43
|
$133.50M | - | 64 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$25.52
|
$110.20M | - | 60 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.94
|
$71.69M | - | 58 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.85
|
$67.94M | - | 56 | Compare |
|
IPSC
Century Therapeutics, Inc. Common Stock
|
$2.38
|
$43.18M | - | 56 | Compare |
More MOLN Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry